Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-10 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |